BIOMAT Database Logo BIOMAT Database Logo

Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia. 2023

Yanfei Shen, and Xinfang Xie
Department of Intensive Care, Zhejiang Hospital, 1229 Gudun Road, Hangzhou, 310013, Zhejiang, China. snow.shen@hotmail.com.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D053717 Pneumonia, Ventilator-Associated Serious INFLAMMATION of the LUNG in patients who required the use of PULMONARY VENTILATOR. It is usually caused by bacterial CROSS INFECTION in hospitals. Ventilator-Associated Pneumonia

Related Publications

Yanfei Shen, and Xinfang Xie
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
August 2007, Critical care medicine,
Yanfei Shen, and Xinfang Xie
Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia.
February 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Yanfei Shen, and Xinfang Xie
Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
June 2011, Pharmacotherapy,
Yanfei Shen, and Xinfang Xie
Pseudomonas aeruginosa: acute lung injury or ventilator-associated pneumonia?
October 2010, Minerva anestesiologica,
Yanfei Shen, and Xinfang Xie
Pseudomonas aeruginosa ventilator-associated pneumonia management.
January 2016, Infection and drug resistance,
Yanfei Shen, and Xinfang Xie
Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia.
October 2011, Minerva anestesiologica,
Yanfei Shen, and Xinfang Xie
Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial.
May 2023, Critical care (London, England),
Yanfei Shen, and Xinfang Xie
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.
July 2013, American journal of respiratory and critical care medicine,
Yanfei Shen, and Xinfang Xie
Ventilator-associated pneumonia due to Pseudomonas aeruginosa.
April 1996, Chest,
Yanfei Shen, and Xinfang Xie
Ventilator-associated Pseudomonas aeruginosa pneumonia: radiographic findings.
April 1995, Radiology,
Copied contents to your clipboard!